PMS2 and Lynch syndrome: Indeed, inactivating mutations in both MLH1 and PMS2 are associated to the Lynch syndrome, a heritable condition associated with a greatly increased risk of colorectal, endometrial, stomach, and ovarian cancers together with tumors of the small intestine, the biliary tract, brain, ureters, and renal pelvis [22].